Company Filing History:
1 out of 1 
1 out of 1 Years Active: 2025
Title: Renhong Tang: Innovator in IL-2 Mutants
Introduction
Renhong Tang is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of biopharmaceuticals, particularly through his work on IL-2 mutants. With a total of 2 patents, his innovations are paving the way for advancements in medical treatments.
Latest Patents
Renhong Tang's latest patents focus on IL-2 mutants and their applications. The disclosures detail the development of IL-2 mutants, including corresponding fusion proteins, conjugates, nucleic acid fragments, vectors, and host cells. These innovations also encompass methods for preparing the mutants or fusion proteins, as well as pharmaceutical compositions and uses. Notably, the IL-2 mutants exhibit higher Tm values and improved stability compared to wild-type IL-2. Additionally, these mutants demonstrate increased yield and altered binding activity to the IL-2Rβγ complexes, enhancing their therapeutic potential.
Career Highlights
Throughout his career, Renhong Tang has worked with prominent companies in the pharmaceutical sector, including Hainan Simcere Pharmaceutical Co., Ltd. and Shandong Simcere Biopharmaceutical Co., Ltd. His experience in these organizations has contributed to his expertise in biopharmaceutical innovations.
Collaborations
Renhong Tang has collaborated with several professionals in his field, including Yingying Hu and Zhuoxiao Cao. These partnerships have likely enriched his research and development efforts.
Conclusion
Renhong Tang's work on IL-2 mutants represents a significant advancement in biopharmaceuticals. His contributions are expected to have a lasting impact on the treatment of various diseases.